Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Neurobiol Aging

Retrieve available abstracts of 288 articles:
HTML format



Single Articles


    August 2022
  1. VIDAL-PINEIRO D, Sorensen O, Blennow K, Capogna E, et al
    Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults.
    Neurobiol Aging. 2022;116:80-91.
    PubMed     Abstract available


  2. SHEN B, Hernandez DG, Chitrala KN, Fanelli-Kuczmarski MT, et al
    APOE gene region methylation is associated with cognitive performance in middle-aged urban adults.
    Neurobiol Aging. 2022;116:41-48.
    PubMed     Abstract available


  3. MELIKYAN ZA, Corrada MM, Leiby AM, Sajjadi SA, et al
    Cognitive resilience to three dementia-related neuropathologies in an oldest-old man: A case report from The 90+ Study.
    Neurobiol Aging. 2022;116:12-15.
    PubMed     Abstract available


    July 2022
  4. JIANG L, Qin Y, Zhao YW, Zeng Q, et al
    PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment.
    Neurobiol Aging. 2022;115:70-76.
    PubMed     Abstract available


  5. FULOPOVA B, Bennett W, Summers BS, Stuart KE, et al
    Cortical axon sub-population maintains density, but not turnover, of en passant boutons in the aged APP/PS1 amyloidosis model.
    Neurobiol Aging. 2022;115:29-38.
    PubMed     Abstract available


  6. TAN CH, Chew J, Zhang L, Gulyas B, et al
    Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness.
    Neurobiol Aging. 2022;115:12-19.
    PubMed     Abstract available


  7. LAPOINT MR, Baker SL, Landau SM, Harrison TM, et al
    Rates of beta-amyloid deposition indicate widespread simultaneous accumulation throughout the brain.
    Neurobiol Aging. 2022;115:1-11.
    PubMed     Abstract available


  8. BROWN SSG, Mak E, Clare I, Grigorova M, et al
    Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome.
    Neurobiol Aging. 2022;115:112-121.
    PubMed     Abstract available


    June 2022
  9. KIM J, Jung SH, Choe YS, Kim S, et al
    Ethnic differences in the frequency of beta-amyloid deposition in cognitively normal individuals.
    Neurobiol Aging. 2022;114:27-37.
    PubMed     Abstract available


  10. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging.
    Neurobiol Aging. 2022;114:15-26.
    PubMed     Abstract available


  11. KIM SJ, Woo SY, Kim YJ, Jang H, et al
    Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.
    Neurobiol Aging. 2022;114:84-93.
    PubMed     Abstract available


  12. HUTTULA S, Vayrynen H, Helisalmi S, Kytovuori L, et al
    NDUFA1 p.Gly32Arg variant in early-onset dementia.
    Neurobiol Aging. 2022;114:113-116.
    PubMed     Abstract available


    May 2022
  13. KHAIRE AS, Wimberly CE, Semmes EC, Hurst JH, et al
    An integrated genome and phenome-wide association study approach to understanding Alzheimer's disease predisposition.
    Neurobiol Aging. 2022 May 27. pii: S0197-4580(22)00120.
    PubMed     Abstract available


  14. MAZZEO S, Polito C, Lassi M, Bagnoli S, et al
    Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline.
    Neurobiol Aging. 2022;117:59-70.
    PubMed     Abstract available


  15. ZHOU XA, Ngiam G, Qian L, Sankorrakul K, et al
    The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
    Neurobiol Aging. 2022;117:24-32.
    PubMed     Abstract available


  16. DONG R, Denier-Fields DN, Lu Q, Suridjan I, et al
    Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers.
    Neurobiol Aging. 2022;117:12-23.
    PubMed     Abstract available


  17. GUISLE I, Canet G, Petry S, Fereydouni-Forouzandeh P, et al
    Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia.
    Neurobiol Aging. 2022;113:118-130.
    PubMed     Abstract available


  18. MORTAMAIS M, Gutierrez LA, Balem M, Bars EL, et al
    Sulcal morphology as cognitive decline predictor in older adults with memory complaints.
    Neurobiol Aging. 2022;113:84-94.
    PubMed     Abstract available


  19. HULSHOF LA, Frajmund LA, van Nuijs D, van der Heijden DCN, et al
    Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.
    Neurobiol Aging. 2022;113:28-38.
    PubMed     Abstract available


  20. QUINTAS-NEVES M, Teylan MA, Morais-Ribeiro R, Almeida F, et al
    Divergent magnetic resonance imaging atrophy patterns in Alzheimer's disease and primary age-related tauopathy.
    Neurobiol Aging. 2022;117:1-11.
    PubMed     Abstract available


    April 2022
  21. XIAO X, Liao X, Zhou Y, Weng L, et al
    Variants in the Niemann-pick type C genes are not associated with Alzheimer's disease: a large case-control study in the Chinese population.
    Neurobiol Aging. 2022;116:49-54.
    PubMed     Abstract available


  22. BABILONI C, Lorenzo I, Lizio R, Lopez S, et al
    Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer's and Lewy body diseases.
    Neurobiol Aging. 2022;115:88-108.
    PubMed     Abstract available


  23. PENG S, Roth AR, Apostolova LG, Saykin AJ, et al
    Cognitively stimulating environments and cognitive reserve: the case of personal social networks.
    Neurobiol Aging. 2022;112:197-203.
    PubMed     Abstract available


  24. MCKAY NS, Dincer A, Mehrotra V, Aschenbrenner AJ, et al
    Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults.
    Neurobiol Aging. 2022;112:181-190.
    PubMed     Abstract available


  25. TRAN TT, Speck CL, Gallagher M, Bakker A, et al
    Lateral entorhinal cortex dysfunction in amnestic mild cognitive impairment.
    Neurobiol Aging. 2022;112:151-160.
    PubMed     Abstract available


  26. ARAKAKI X, Hung SM, Rochart R, Fonteh AN, et al
    Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau.
    Neurobiol Aging. 2022;112:87-101.
    PubMed     Abstract available


  27. JOHNSON AG, Webster JA, Hales CM
    Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration.
    Neurobiol Aging. 2022;112:55-73.
    PubMed     Abstract available


  28. KARA F, Joers JM, Deelchand DK, Park YW, et al
    (1)H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.
    Neurobiol Aging. 2022;112:16-26.
    PubMed     Abstract available


    March 2022
  29. LI Y, Macyczko JR, Liu CC, Bu G, et al
    ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Neurobiol Aging. 2022;115:20-28.
    PubMed     Abstract available


  30. WOODFIELD A, Porter T, Gilani I, Noordin S, et al
    Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Abeta42 moderates the association between insulin resistance and increased CSF tau levels.
    Neurobiol Aging. 2022;114:38-48.
    PubMed     Abstract available


  31. SCHEIJBELER EP, Schoonhoven DN, Engels MMA, Scheltens P, et al
    Generating diagnostic profiles of cognitive decline and dementia using magnetoencephalography.
    Neurobiol Aging. 2022;111:82-94.
    PubMed     Abstract available


  32. DUGAN AJ, Nelson PT, Katsumata Y, Shade LMP, et al
    Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes.
    Neurobiol Aging. 2022;111:95-106.
    PubMed     Abstract available


    February 2022
  33. RIPHAGEN JM, Suresh MB, Salat DH
    The canonical pattern of Alzheimer's disease atrophy is linked to white matter hyperintensities in normal controls, differently in normal controls compared to in AD.
    Neurobiol Aging. 2022 Feb 28. pii: S0197-4580(22)00029.
    PubMed     Abstract available


  34. CLEMENT AN, Ribaldi F, Frisoni GB, Garibotto V, et al
    SimulAD: a dynamical model for personalized simulation and disease staging in Alzheimer's disease.
    Neurobiol Aging. 2022;113:73-83.
    PubMed     Abstract available


  35. CATANIA M, Marti A, Rossi G, Fioretti A, et al
    The novel I213S mutation in PSEN1 gene is located in a hotspot codon associated with familial early-onset Alzheimer's disease.
    Neurobiol Aging. 2022;112:191-196.
    PubMed     Abstract available


  36. MALBON AJ, Sordo L, Wilson LA, Gunn-Moore D, et al
    Alzheimer-like pathology in the parietal cortex and hippocampus of aged donkeys.
    Neurobiol Aging. 2022;113:7-14.
    PubMed     Abstract available


  37. NOVY MJ, Newbury SF, Liemisa B, Morales-Corraliza J, et al
    Expression and proteolytic processing of the amyloid precursor protein is unaffected by the expression of the three human apolipoprotein E alleles in the brains of mice.
    Neurobiol Aging. 2022;110:73-76.
    PubMed     Abstract available


    January 2022
  38. LIANG X, Liu C, Liu K, Cong L, et al
    Association and interaction of TOMM40 and PVRL2 with plasma amyloid-beta and Alzheimer's disease among Chinese older adults: a population-based study.
    Neurobiol Aging. 2022 Jan 5. pii: S0197-4580(21)00370.
    PubMed     Abstract available


  39. OLTRA-CUCARELLA J, Sanchez-SanSegundo M, Ferrer-Cascales R
    Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.
    Neurobiol Aging. 2022;112:111-121.
    PubMed     Abstract available


  40. INKSTER AM, Duarte-Guterman P, Albert AY, Barha CK, et al
    Are sex differences in cognitive impairment reflected in epigenetic age acceleration metrics?
    Neurobiol Aging. 2022;109:192-194.
    PubMed     Abstract available


  41. LI T, Pappas C, Le ST, Wang Q, et al
    APOE, TOMM40, and sex interactions on neural network connectivity.
    Neurobiol Aging. 2022;109:158-165.
    PubMed     Abstract available


  42. YOON B, Guo T, Provost K, Korman D, et al
    Abnormal tau in amyloid PET negative individuals.
    Neurobiol Aging. 2022;109:125-134.
    PubMed     Abstract available


    December 2021
  43. TAXIER LR, Philippi SM, York JM, LaDu MJ, et al
    The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha.
    Neurobiol Aging. 2021;112:74-86.
    PubMed     Abstract available


  44. DAHL MJ, Mather M, Werkle-Bergner M, Kennedy BL, et al
    Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease.
    Neurobiol Aging. 2021;112:39-54.
    PubMed     Abstract available


  45. DADAR M, Manera AL, Ducharme S, Collins DL, et al
    White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Neurobiol Aging. 2021;111:54-63.
    PubMed     Abstract available


  46. RAMANAN S, Foxe D, El-Omar H, Ahmed RM, et al
    Evidence for a pervasive autobiographical memory impairment in Logopenic Progressive Aphasia.
    Neurobiol Aging. 2021;108:168-178.
    PubMed     Abstract available


  47. VAN DEN BOSCH KA, Verberk IMW, Ebenau JL, van der Lee SJ, et al
    BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project.
    Neurobiol Aging. 2021;108:146-154.
    PubMed     Abstract available


  48. FRANZ CE, Hatton SN, Elman JA, Warren T, et al
    Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age.
    Neurobiol Aging. 2021;108:80-89.
    PubMed     Abstract available


  49. SAMIMI N, Sharma G, Kimura T, Matsubara T, et al
    Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Neurobiol Aging. 2021;108:72-79.
    PubMed     Abstract available


  50. HU B, Geng C, Guo F, Liu Y, et al
    GABAA receptor agonist muscimol rescues inhibitory microcircuit defects in the olfactory bulb and improves olfactory function in APP/PS1 transgenic mice.
    Neurobiol Aging. 2021;108:47-57.
    PubMed     Abstract available


    November 2021
  51. PINI L, Pizzini FB, Boscolo-Galazzo I, Ferrari C, et al
    Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation.
    Neurobiol Aging. 2021;111:24-34.
    PubMed     Abstract available


  52. MECCA AP, Chen MK, O'Dell RS, Naganawa M, et al
    Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.
    Neurobiol Aging. 2021;111:44-53.
    PubMed     Abstract available


  53. FRANCIOTTI R, Moretti DV, Benussi A, Ferri L, et al
    Cortical network modularity changes along the course of frontotemporal and Alzheimer's dementing diseases.
    Neurobiol Aging. 2021;110:37-46.
    PubMed     Abstract available


  54. EKBLAD LL, Visser PJ, Tijms BM
    Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid1-42.
    Neurobiol Aging. 2021;107:42-52.
    PubMed     Abstract available


  55. SHAROAR MG, Zhou J, Benoit M, He W, et al
    Dynactin 6 deficiency enhances aging-associated dystrophic neurite formation in mouse brains.
    Neurobiol Aging. 2021;107:21-29.
    PubMed     Abstract available


    October 2021
  56. JONIN PY, Duche Q, Bannier E, Corouge I, et al
    Building memories on prior knowledge: behavioral and fMRI evidence of impairment in early Alzheimer's disease.
    Neurobiol Aging. 2021;110:1-12.
    PubMed     Abstract available


  57. KO K, Yi D, Byun MS, Lee JH, et al
    Cognitive reserve proxies, Alzheimer pathologies, and cognition.
    Neurobiol Aging. 2021;110:88-95.
    PubMed     Abstract available


  58. ZHANG H, Wang H, Gao F, Yang J, et al
    TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
    Neurobiol Aging. 2021;106:292-303.
    PubMed     Abstract available


  59. KOINUMA S, Shimozawa N, Yasutomi Y, Kimura N, et al
    Aging induces abnormal accumulation of Abeta in extracellular vesicle and/or intraluminal membrane vesicle-rich fractions in nonhuman primate brain.
    Neurobiol Aging. 2021;106:268-281.
    PubMed     Abstract available


  60. VAN DER THIEL MM, Freeze WM, Verheggen ICM, Wong SM, et al
    Associations of increased interstitial fluid with vascular and neurodegenerative abnormalities in a memory clinic sample.
    Neurobiol Aging. 2021;106:257-267.
    PubMed     Abstract available


  61. LEE YG, Park M, Jeong SH, Kang SW, et al
    Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism.
    Neurobiol Aging. 2021;106:223-231.
    PubMed     Abstract available


  62. CULLELL N, Carcel-Marquez J, Gallego-Fabrega C, Muino E, et al
    Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study.
    Neurobiol Aging. 2021;106:320.
    PubMed     Abstract available


  63. LORD J, Zettergren A, Ashton NJ, Karikari TK, et al
    A genome-wide association study of plasma phosphorylated tau181.
    Neurobiol Aging. 2021;106:304.
    PubMed     Abstract available


    September 2021
  64. HONE-BLANCHET A, Bohsali A, Krishnamurthy LC, Shahid S, et al
    Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults.
    Neurobiol Aging. 2021;109:22-30.
    PubMed     Abstract available


  65. KULMINSKI AM, Philipp I, Shu L, Culminskaya I, et al
    Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk.
    Neurobiol Aging. 2021 Sep 15. pii: S0197-4580(21)00290.
    PubMed     Abstract available


  66. KOENIG LN, LaMontagne P, Glasser MF, Bateman R, et al
    Regional age-related atrophy after screening for preclinical alzheimer disease.
    Neurobiol Aging. 2021;109:43-51.
    PubMed     Abstract available


  67. CHARISSE D, Erus G, Pomponio R, Gorges M, et al
    Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
    Neurobiol Aging. 2021;109:31-42.
    PubMed     Abstract available


  68. BONOMI CG, De Lucia V, Mascolo AP, Assogna M, et al
    Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias.
    Neurobiol Aging. 2021;105:333-339.
    PubMed     Abstract available


  69. OLAJIDE OJ, Chapman CA
    Amyloid-beta (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex.
    Neurobiol Aging. 2021;105:296-309.
    PubMed     Abstract available


  70. ENNIS GE, Kohli A, Jonaitis EM, Betthauser TJ, et al
    The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.
    Neurobiol Aging. 2021;105:174-185.
    PubMed     Abstract available


  71. QUINTANA DD, Anantula Y, Garcia JA, Engler-Chiurazzi EB, et al
    Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice.
    Neurobiol Aging. 2021;105:115-128.
    PubMed     Abstract available


  72. CARLYLE BC, Kandigian SE, Kreuzer J, Das S, et al
    Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.
    Neurobiol Aging. 2021;105:99-114.
    PubMed     Abstract available


  73. SIBLE IJ, Yew B, Dutt S, Bangen KJ, et al
    Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults.
    Neurobiol Aging. 2021;105:57-63.
    PubMed     Abstract available


  74. KNIGHT SP, Laird E, Williamson W, O'Connor J, et al
    Obesity is associated with reduced cerebral blood flow - modified by physical activity.
    Neurobiol Aging. 2021;105:35-47.
    PubMed     Abstract available


    August 2021
  75. WHITWELL JL, Tosakulwong N, Weigand SD, Graff-Radford J, et al
    Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.
    Neurobiol Aging. 2021;108:90-98.
    PubMed     Abstract available


  76. ZHANG Z, Wang M, Liu X
    C-reactive protein and risk of Alzheimer's disease.
    Neurobiol Aging. 2021 Aug 21. pii: S0197-4580(21)00264.
    PubMed     Abstract available


  77. PALIWAL D, McInerney TW, Pa J, Swerdlow RH, et al
    Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.
    Neurobiol Aging. 2021 Aug 18. pii: S0197-4580(21)00259.
    PubMed     Abstract available


  78. SHEPHERD A, Lim JKH, Wong VHY, Zeleznikow-Johnston AM, et al
    Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.
    Neurobiol Aging. 2021;108:58-71.
    PubMed     Abstract available


  79. WILLEMSE EAJ, Sieben A, Somers C, Vermeiren Y, et al
    Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;108:99-109.
    PubMed     Abstract available


  80. BELFIORE ACR, Oddo S
    Retraction notice to "Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease" [Neurobiology of Aging Volume 68, August 2018, Page 59-67].
    Neurobiol Aging. 2021;104:139.
    PubMed    


  81. SHAFER AT, Beason-Held L, An Y, Williams OA, et al
    Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype.
    Neurobiol Aging. 2021;104:10-23.
    PubMed     Abstract available


    July 2021
  82. FLEMING V, Piro-Gambetti B, Patrick A, Zammit M, et al
    Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome.
    Neurobiol Aging. 2021;107:118-127.
    PubMed     Abstract available


  83. TATARYN NM, Singh V, Dyke JP, Berk-Rauch HE, et al
    Vascular endothelial growth factor associated dissimilar cerebrovascular phenotypes in two different mouse models of Alzheimer's Disease.
    Neurobiol Aging. 2021;107:96-108.
    PubMed     Abstract available


  84. IONESCU-TUCKER A, Cotman CW
    Emerging roles of oxidative stress in brain aging and Alzheimer's disease.
    Neurobiol Aging. 2021;107:86-95.
    PubMed     Abstract available


  85. LIM B, Grontvedt GR, Bathala P, Kale SS, et al
    CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;107:78-85.
    PubMed     Abstract available


  86. MIN S, Li Z, Shieh A, Giase G, et al
    Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer's Disease based on the analysis of multi-omics data.
    Neurobiol Aging. 2021 Jul 21. pii: S0197-4580(21)00236.
    PubMed     Abstract available


  87. LEMERCIER P, Vergallo A, Lista S, Zetterberg H, et al
    Association of plasma Abeta40/Abeta42 ratio and brain Abeta accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease.
    Neurobiol Aging. 2021;107:57-69.
    PubMed     Abstract available


  88. NAUDE PJW, Ramakers IHGB, van der Flier WM, Jiskoot LC, et al
    Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia.
    Neurobiol Aging. 2021;107:1-10.
    PubMed     Abstract available


  89. VAN DER LINDEN RJ, Reus LM, De Witte W, Tijms BM, et al
    Genetic overlap between Alzheimer's disease and blood lipid levels.
    Neurobiol Aging. 2021 Jul 3. pii: S0197-4580(21)00213.
    PubMed     Abstract available


  90. CEYZERIAT K, Zilli T, Fall AB, Millet P, et al
    Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model.
    Neurobiol Aging. 2021;103:117-127.
    PubMed     Abstract available


  91. XU W, Tan CC, Cao XP, Tan L, et al
    Neuroinflammation modulates the association of PGRN with cerebral amyloid-beta burden.
    Neurobiol Aging. 2021;103:52-59.
    PubMed     Abstract available


    June 2021
  92. RUSSO ML, Molina-Campos E, Ybarra N, Rogalsky AE, et al
    Variability in sub-threshold signaling linked to Alzheimer's disease emerges with age and amyloid plaque deposition in mouse ventral CA1 pyramidal neurons.
    Neurobiol Aging. 2021;106:207-222.
    PubMed     Abstract available


  93. ZADEY S, Buss SS, McDonald K, Press DZ, et al
    Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.
    Neurobiol Aging. 2021;108:24-33.
    PubMed     Abstract available


  94. PFEIL J, Hoenig MC, Doering E, van Eimeren T, et al
    Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease.
    Neurobiol Aging. 2021;106:119-129.
    PubMed     Abstract available


  95. JUNG JH, Jeon S, Baik K, Lee YH, et al
    Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.
    Neurobiol Aging. 2021;106:45-54.
    PubMed     Abstract available


  96. SANGHA O, Ma D, Popuri K, Stocks J, et al
    Structural volume and cortical thickness differences between males and females in cognitively normal, cognitively impaired and Alzheimer's dementia population.
    Neurobiol Aging. 2021;106:1-11.
    PubMed     Abstract available


  97. BANKS SJ, Andrews MJ, Digma L, Madsen J, et al
    Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?
    Neurobiol Aging. 2021;107:70-77.
    PubMed     Abstract available


  98. BUTT OH, Long JM, Henson RL, Herries E, et al
    Cognitively normal APOE epsilon4 carriers have specific elevation of CSF SNAP-25.
    Neurobiol Aging. 2021;102:64-72.
    PubMed     Abstract available


    May 2021
  99. XIAO X, Yuan Z, Guo L, Liao X, et al
    The role of frontotemporal dementia associated genes in patients with Alzheimer's disease.
    Neurobiol Aging. 2021 May 30. pii: S0197-4580(21)00179.
    PubMed     Abstract available


  100. TUBI MA, Kothapalli D, Hapenney M, Feingold FW, et al
    Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition.
    Neurobiol Aging. 2021;105:241-251.
    PubMed     Abstract available


  101. GAUBERT S, Houot M, Raimondo F, Ansart M, et al
    A machine learning approach to screen for preclinical Alzheimer's disease.
    Neurobiol Aging. 2021;105:205-216.
    PubMed     Abstract available


  102. BOSSAERTS L, Hens E, Hanseeuw B, Vandenberghe R, et al
    Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients.
    Neurobiol Aging. 2021 May 2. pii: S0197-4580(21)00146.
    PubMed     Abstract available


  103. BEHESHTI I, Nugent S, Potvin O, Duchesne S, et al
    Disappearing metabolic youthfulness in the cognitively impaired female brain.
    Neurobiol Aging. 2021;101:224-229.
    PubMed     Abstract available


  104. KRONENBERG G, Gertz K, Schoner J, Bertram L, et al
    BDNF serum concentrations in 2053 participants of the Berlin Aging Study II.
    Neurobiol Aging. 2021;101:221-223.
    PubMed     Abstract available


  105. BELLOY ME, Eger SJ, Le Guen Y, Napolioni V, et al
    KL *VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE *4 carriers.
    Neurobiol Aging. 2021;101:123-129.
    PubMed     Abstract available


  106. ZUO Z, Qi F, Xing Z, Yuan L, et al
    Bacille Calmette-Guerin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-beta immunotherapy.
    Neurobiol Aging. 2021;101:94-108.
    PubMed     Abstract available


  107. SMITH GS, Kuwabara H, Nandi A, Gould NF, et al
    Molecular imaging of beta-amyloid deposition in late-life depression.
    Neurobiol Aging. 2021;101:85-93.
    PubMed     Abstract available


  108. ASTROSKI JW, Akporyoe LK, Androphy EJ, Custer SK, et al
    Mutations in the COPI coatomer subunit alpha-COP induce release of Abeta-42 and amyloid precursor protein intracellular domain and increase tau oligomerization and release.
    Neurobiol Aging. 2021;101:57-69.
    PubMed     Abstract available


    April 2021
  109. TSAKIRI EN, Gumeni S, Manola MS, Trougakos IP, et al
    Amyloid toxicity in a Drosophila Alzheimer's model is ameliorated by autophagy activation.
    Neurobiol Aging. 2021;105:137-147.
    PubMed     Abstract available


  110. EDWARDS L, La Joie R, Iaccarino L, Strom A, et al
    Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
    Neurobiol Aging. 2021;105:86-98.
    PubMed     Abstract available


  111. RABIPOUR S, Rajagopal S, Pasvanis S, Rajah MN, et al
    Generalization of memory-related brain function in asymptomatic older women with a family history of late onset Alzheimer's Disease: Results from the PREVENT-AD Cohort.
    Neurobiol Aging. 2021;104:42-56.
    PubMed     Abstract available


  112. OBERRAUCH S, Metha JA, Brian ML, Barnes SA, et al
    Reward motivation and cognitive flexibility in tau null-mutation mice.
    Neurobiol Aging. 2021;100:106-117.
    PubMed     Abstract available


  113. OUK M, Wu CY, Rabin JS, Edwards JD, et al
    Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
    Neurobiol Aging. 2021;100:22-31.
    PubMed     Abstract available


    March 2021
  114. HOOGMARTENS J, Hens E, Engelborghs S, De Deyn PP, et al
    Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease.
    Neurobiol Aging. 2021 Mar 28. pii: S0197-4580(21)00102.
    PubMed     Abstract available


  115. CASH MK, Rockwood K, Fisk JD, Darvesh S, et al
    Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
    Neurobiol Aging. 2021;103:31-41.
    PubMed     Abstract available


  116. HU K, Li P, Gao L
    Sleep, rest-activity rhythms and aging: a complex web in Alzheimer's disease?
    Neurobiol Aging. 2021 Mar 2. pii: S0197-4580(21)00072.
    PubMed    


  117. MESQUITA LLR, Mesquita LP, Wadt D, Bruhn FRP, et al
    Heterogenous deposition of beta-amyloid in the brain of aged dogs.
    Neurobiol Aging. 2021;99:44-52.
    PubMed     Abstract available


    February 2021
  118. NUEBLING GS, Prix C, Brendel M, Beyer L, et al
    Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease.
    Neurobiol Aging. 2021 Feb 28. pii: S0197-4580(21)00076.
    PubMed     Abstract available


  119. CACCIOTTOLO M, Morgan TE, Finch CE
    Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.
    Neurobiol Aging. 2021;103:42-51.
    PubMed     Abstract available


  120. RAJABLI F, Feliciano-Astacio BE, Cukier HN, Wang L, et al
    Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus.
    Neurobiol Aging. 2021 Feb 28. pii: S0197-4580(21)00074.
    PubMed     Abstract available


  121. BETTCHER BM, Olson KE, Carlson NE, McConnell BV, et al
    Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease.
    Neurobiol Aging. 2021;103:68-77.
    PubMed     Abstract available


  122. KARA F, Belloy ME, Voncken R, Sarwari Z, et al
    Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease.
    Neurobiol Aging. 2021;102:139-150.
    PubMed     Abstract available


  123. RUBINSKI A, Tosun D, Franzmeier N, Neitzel J, et al
    Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.
    Neurobiol Aging. 2021;102:111-118.
    PubMed     Abstract available


  124. VAN HOOREN RWE, Verhey FRJ, Ramakers IHGB, Jansen WJ, et al
    Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer's disease pathology.
    Neurobiol Aging. 2021;102:17-22.
    PubMed     Abstract available


  125. GIOVAGNONI C, Ali M, Eijssen LMT, Maes R, et al
    Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach.
    Neurobiol Aging. 2021;102:178-187.
    PubMed     Abstract available


  126. O'CONNOR A, Abel E, Fraser MR, Ryan NS, et al
    A novel presenilin 1 duplication mutation (Ile168dup) causing Alzheimer's disease associated with myoclonus, seizures and pyramidal features.
    Neurobiol Aging. 2021 Feb 5. pii: S0197-4580(21)00046.
    PubMed     Abstract available


  127. ALLISON SL, Jonaitis EM, Koscik RL, Hermann BP, et al
    Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.
    Neurobiol Aging. 2021;102:151-160.
    PubMed     Abstract available


  128. CHUNG SJ, Lee S, Yoo HS, Baik K, et al
    Different patterns of beta-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism.
    Neurobiol Aging. 2021;101:199-206.
    PubMed     Abstract available


  129. KIM BH, Nho K, Lee JM
    Genome-wide association study identifies susceptibility loci of brain atrophy to NFIA and ST18 in Alzheimer's disease.
    Neurobiol Aging. 2021 Feb 3. pii: S0197-4580(21)00028.
    PubMed     Abstract available


  130. WISSE LEM, Ungrady MB, Ittyerah R, Lim SA, et al
    Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.
    Neurobiol Aging. 2021;98:231-241.
    PubMed     Abstract available


  131. GUO C, Zhang Y, Nie Q, Cao D, et al
    SQSTM1/ p62 oligomerization contributes to Abeta-induced inhibition of Nrf2 signaling.
    Neurobiol Aging. 2021;98:10-20.
    PubMed     Abstract available


  132. MUSCAT SM, Deems NP, D'Angelo H, Kitt MM, et al
    Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats.
    Neurobiol Aging. 2021;98:214-224.
    PubMed     Abstract available


  133. YEUNG LK, Hale C, Rizvi B, Igwe K, et al
    Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adults.
    Neurobiol Aging. 2021;98:134-145.
    PubMed     Abstract available


  134. LOW A, Su L, Stefaniak JD, Mak E, et al
    Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
    Neurobiol Aging. 2021;98:124-133.
    PubMed     Abstract available


  135. MEEKER KL, Ances BM, Gordon BA, Rudolph CW, et al
    Cerebrospinal fluid Abeta42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability.
    Neurobiol Aging. 2021;98:116-123.
    PubMed     Abstract available


    January 2021
  136. PARK JE, Lee YJ, Byun MS, Yi D, et al
    Differential associations of age and Alzheimer's disease with sleep and rest-activity rhythms across the adult lifespan.
    Neurobiol Aging. 2021;101:141-149.
    PubMed     Abstract available


  137. MONDRAGON JD, Maurits NM, De Deyn PP
    Functional connectivity differences in Alzheimer's disease and amnestic mild cognitive impairment associated with AT(N) classification and anosognosia.
    Neurobiol Aging. 2021;101:22-39.
    PubMed     Abstract available


  138. CHENG Z, Shang Y, Xu X, Dong Z, et al
    Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease-like symptoms.
    Neurobiol Aging. 2021;100:1-10.
    PubMed     Abstract available


  139. DECKER Y, Nemeth E, Schomburg R, Chemla A, et al
    Decreased pH in the aging brain and Alzheimer's disease.
    Neurobiol Aging. 2021;101:40-49.
    PubMed     Abstract available


  140. PALTA P, Rippon B, Tahmi M, Sherwood G, et al
    Metabolic syndrome and its components in relation to in vivo brain amyloid and neurodegeneration in late middle age.
    Neurobiol Aging. 2021;97:89-96.
    PubMed     Abstract available


    December 2020
  141. MIYAGAWA T, Przybelski SA, Maltais D, Min HK, et al
    The value of multimodal imaging with (123)I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia.
    Neurobiol Aging. 2020;99:11-18.
    PubMed     Abstract available


  142. BAE J, Stocks J, Heywood A, Jung Y, et al
    Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.
    Neurobiol Aging. 2020;99:53-64.
    PubMed     Abstract available


  143. MARCA-YSABEL MV, Rajabli F, Cornejo-Olivas M, Whitehead PG, et al
    Dissecting the role of Amerindian genetic ancestry and the ApoE epsilon4 allele on Alzheimer disease in an admixed Peruvian population.
    Neurobiol Aging. 2020 Dec 10. pii: S0197-4580(20)30312.
    PubMed     Abstract available


  144. WENG FL, He L
    Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.
    Neurobiol Aging. 2020;99:79-85.
    PubMed     Abstract available


    November 2020
  145. YANG W, Zhou X, Ryazanov AG, Ma T, et al
    Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;98:225-230.
    PubMed     Abstract available


  146. LAWINGCO T, Chaudhury S, Brookes KJ, Guetta-Baranes T, et al
    Genetic variants in glutamate-, Abeta-, and tau-related pathways determine polygenic risk for Alzheimer's disease.
    Neurobiol Aging. 2020 Nov 12. pii: S0197-4580(20)30391.
    PubMed     Abstract available


  147. ZHUANG Z, Gao M, Yang R, Liu Z, et al
    Causal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study.
    Neurobiol Aging. 2020 Nov 12. pii: S0197-4580(20)30334.
    PubMed     Abstract available


  148. FOO H, Thalamuthu A, Jiang J, Koch F, et al
    Associations between Alzheimer's disease polygenic risk scores and hippocampal subfield volumes in 17,161 UK Biobank participants.
    Neurobiol Aging. 2020;98:108-115.
    PubMed     Abstract available


  149. MANZALI SB, Ravona-Springer R, Alkelai A, Yu E, et al
    Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Neurobiol Aging. 2020;101:50-56.
    PubMed     Abstract available


  150. MURRAY AN, Chandler HL, Lancaster TM
    Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease.
    Neurobiol Aging. 2020;98:33-41.
    PubMed     Abstract available


    October 2020
  151. SALAZAR AM, Leisgang AM, Ortiz AA, Murtishaw AS, et al
    Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;97:129-143.
    PubMed     Abstract available


  152. GAUBA E, Sui S, Tian J, Driskill C, et al
    Modulation of OSCP mitigates mitochondrial and synaptic deficits in a mouse model of Alzheimer's pathology.
    Neurobiol Aging. 2020;98:63-77.
    PubMed     Abstract available


  153. HENDRIX RD, Ou Y, Davis JE, Odle AK, et al
    Alzheimer amyloid-beta- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood.
    Neurobiol Aging. 2020;97:73-88.
    PubMed     Abstract available


  154. KWOK MK, Schooling CM
    Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study.
    Neurobiol Aging. 2020 Oct 9. pii: S0197-4580(20)30309.
    PubMed     Abstract available


  155. PAES D, Lardenoije R, Carollo RM, Roubroeks JAY, et al
    Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease.
    Neurobiol Aging. 2020;97:56-64.
    PubMed     Abstract available


  156. LIU D, Wang Y, Jing H, Meng Q, et al
    Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.
    Neurobiol Aging. 2020;97:18-27.
    PubMed     Abstract available


    September 2020
  157. FULTON-HOWARD B, Goate AM, Adelson RP, Koppel J, et al
    Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-epsilon4 carriers.
    Neurobiol Aging. 2020 Sep 30. pii: S0197-4580(20)30291.
    PubMed     Abstract available


  158. WALSH P, Sudre CH, Fiford CM, Ryan NS, et al
    The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
    Neurobiol Aging. 2020;97:10-17.
    PubMed     Abstract available


  159. HOOGMARTENS J, Hens E, Engelborghs S, Vandenberghe R, et al
    Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
    Neurobiol Aging. 2020 Sep 12. pii: S0197-4580(20)30286.
    PubMed     Abstract available


  160. GUO B, Huang Y, Gao Q, Zhou Q, et al
    Stabilization of microtubules improves cognitive functions and axonal transport of mitochondria in Alzheimer's disease model mice.
    Neurobiol Aging. 2020;96:223-232.
    PubMed     Abstract available


  161. MASSA F, Grisanti S, Brugnolo A, Doglione E, et al
    The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease.
    Neurobiol Aging. 2020;96:117-127.
    PubMed     Abstract available


  162. CACERES A, Gonzalez JR
    Female-specific risk of Alzheimer's disease is associated with tau phosphorylation processes: A transcriptome-wide interaction analysis.
    Neurobiol Aging. 2020;96:104-108.
    PubMed     Abstract available


  163. FRANCIOTTI R, Pilotto A, Moretti DV, Falasca NW, et al
    Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study.
    Neurobiol Aging. 2020;93:55-60.
    PubMed     Abstract available


  164. CODY KA, Piro-Gambetti B, Zammit MD, Christian BT, et al
    Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome.
    Neurobiol Aging. 2020;93:44-51.
    PubMed     Abstract available


  165. RAMOS-CAMPOY O, Antonell A, Falgas N, Balasa M, et al
    Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants.
    Neurobiol Aging. 2020;93:e1-e9.
    PubMed     Abstract available


  166. RABIN JS, Shirzadi Z, Swardfager W, MacIntosh BJ, et al
    Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.
    Neurobiol Aging. 2020;93:124-130.
    PubMed     Abstract available


    August 2020
  167. MILLAR PR, Ances BM, Gordon BA, Benzinger TLS, et al
    Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease.
    Neurobiol Aging. 2020;96:233-245.
    PubMed     Abstract available


    July 2020
  168. ANDERSSON E, Janelidze S, Lampinen B, Nilsson M, et al
    Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
    Neurobiol Aging. 2020;95:143-153.
    PubMed     Abstract available


  169. BERTOUX M, Cassagnaud P, Lebouvier T, Lebert F, et al
    Does amnesia specifically predict Alzheimer's pathology? A neuropathological study.
    Neurobiol Aging. 2020;95:123-130.
    PubMed     Abstract available


  170. RUSSO-SAVAGE L, Rao VKS, Eipper BA, Mains RE, et al
    Role of Kalirin and mouse strain in retention of spatial memory training in an Alzheimer's disease model mouse line.
    Neurobiol Aging. 2020;95:69-80.
    PubMed     Abstract available


  171. RINGLAND C, Schweig JE, Paris D, Shackleton B, et al
    Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
    Neurobiol Aging. 2020;95:56-68.
    PubMed     Abstract available


  172. ROUBROEKS JAY, Smith AR, Smith RG, Pishva E, et al
    An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene.
    Neurobiol Aging. 2020;95:26-45.
    PubMed     Abstract available


  173. BROKAW DL, Piras IS, Mastroeni D, Weisenberger DJ, et al
    Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets.
    Neurobiol Aging. 2020;95:15-25.
    PubMed     Abstract available


  174. JAMERLAN A, An SSA
    The influence of Abeta-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC.
    Neurobiol Aging. 2020;95:161-167.
    PubMed     Abstract available


  175. DOUNAVI ME, Mak E, Wells K, Ritchie K, et al
    Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia.
    Neurobiol Aging. 2020;91:36-44.
    PubMed     Abstract available


  176. ZHOU F, Yan XD, Wang C, He YX, et al
    Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice.
    Neurobiol Aging. 2020;91:66-75.
    PubMed     Abstract available


    June 2020
  177. HALLAM B, Chan J, Gonzalez Costafreda S, Bhome R, et al
    What are the neural correlates of meta-cognition and anosognosia in Alzheimer's disease? A systematic review.
    Neurobiol Aging. 2020;94:250-264.
    PubMed     Abstract available


  178. NICASTRO N, Malpetti M, Mak E, Williams GB, et al
    Gray matter changes related to microglial activation in Alzheimer's disease.
    Neurobiol Aging. 2020;94:236-242.
    PubMed     Abstract available


  179. CHANDRA A, Farrell C, Wilson H, Dervenoulas G, et al
    Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum.
    Neurobiol Aging. 2020;97:1-9.
    PubMed     Abstract available


  180. ELMAN JA, Vuoksimaa E, Franz CE, Kremen WS, et al
    Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.
    Neurobiol Aging. 2020;94:149-153.
    PubMed     Abstract available


  181. VANZULLI I, Papanikolaou M, De-La-Rocha IC, Pieropan F, et al
    Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;94:130-139.
    PubMed     Abstract available


  182. BAUER CE, Brown CA, Gold BT
    Education does not protect cognitive function from brain pathology in the ADNI 2 cohort.
    Neurobiol Aging. 2020;90:147-149.
    PubMed     Abstract available


    May 2020
  183. SUGARMAN MA, Zetterberg H, Blennow K, Tripodis Y, et al
    A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
    Neurobiol Aging. 2020;94:60-70.
    PubMed     Abstract available


  184. SIVERA R, Capet N, Manera V, Fabre R, et al
    Voxel-based assessments of treatment effects on longitudinal brain changes in the Multidomain Alzheimer Preventive Trial cohort.
    Neurobiol Aging. 2020;94:50-59.
    PubMed     Abstract available


  185. DICKS E, van der Flier WM, Scheltens P, Barkhof F, et al
    Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.
    Neurobiol Aging. 2020;94:71-80.
    PubMed     Abstract available


  186. DONG JW, Jelescu IO, Ades-Aron B, Novikov DS, et al
    Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition.
    Neurobiol Aging. 2020;89:118-128.
    PubMed     Abstract available


  187. JIAO B, Zhou L, Zhou Y, Weng L, et al
    Identification of expanded repeats in NOTCH2NLC in neurodegenerative dementias.
    Neurobiol Aging. 2020;89:142.
    PubMed     Abstract available


  188. MARIZZONI M, Ferrari C, Babiloni C, Albani D, et al
    CSF cutoffs for MCI due to AD depend on APOEepsilon4 carrier status.
    Neurobiol Aging. 2020;89:55-62.
    PubMed     Abstract available


  189. VAN OLST L, Verhaege D, Franssen M, Kamermans A, et al
    Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    Neurobiol Aging. 2020;89:89-98.
    PubMed     Abstract available


  190. HAMANO T, Shirafuji N, Yen SH, Yoshida H, et al
    Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
    Neurobiol Aging. 2020;89:41-54.
    PubMed     Abstract available


    April 2020
  191. BELLOU E, Baker E, Leonenko G, Bracher-Smith M, et al
    Age-dependent effect of APOE and polygenic component on Alzheimer's disease.
    Neurobiol Aging. 2020;93:69-77.
    PubMed     Abstract available


  192. WANG H, Yang J, Schneider JA, De Jager PL, et al
    Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease.
    Neurobiol Aging. 2020;93:61-68.
    PubMed     Abstract available


  193. VENKATARAMAN L, He P, Schulz P, Sierks MR, et al
    Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.
    Neurobiol Aging. 2020;94:7-14.
    PubMed     Abstract available


  194. AL-EDRESI S, Alsalahat I, Freeman S, Aojula H, et al
    Resveratrol-mediated cleavage of amyloid beta1-42 peptide: potential relevance to Alzheimer's disease.
    Neurobiol Aging. 2020;94:24-33.
    PubMed     Abstract available


  195. HUO Z, Yu L, Yang J, Zhu Y, et al
    Corrigendum to brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis [Neurobiology of Aging Volume 86, February 2020, Pages 123-133].
    Neurobiol Aging. 2020 Apr 18. pii: S0197-4580(20)30123.
    PubMed    


  196. KAUR H, Nagamoto-Combs K, Golovko S, Golovko MY, et al
    Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2020;92:114-134.
    PubMed     Abstract available


  197. BUCIUC M, Whitwell JL, Tosakulwong N, Weigand SD, et al
    Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.
    Neurobiol Aging. 2020;92:92-97.
    PubMed     Abstract available


  198. YUAN C, Aierken A, Xie Z, Li N, et al
    The age-related microglial transformation in Alzheimer's disease pathogenesis.
    Neurobiol Aging. 2020;92:82-91.
    PubMed     Abstract available


  199. SAWKULYCZ X, Bradburn S, Robinson A, Payton A, et al
    Regulation of interleukin 6 by a polymorphic CpG within the frontal cortex in Alzheimer's disease.
    Neurobiol Aging. 2020;92:75-81.
    PubMed     Abstract available


  200. FERREIRO E, Lanzillo M, Canhoto D, Carvalho da Silva AM, et al
    Chronic hyperglycemia impairs hippocampal neurogenesis and memory in an Alzheimer's disease mouse model.
    Neurobiol Aging. 2020;92:98-113.
    PubMed     Abstract available


  201. SMAILOVIC U, Koenig T, Kareholt I, Andersson T, et al
    Corrigendum to Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers Neurobiology of Aging 63 (2018) 88-95.
    Neurobiol Aging. 2020 Apr 9. pii: S0197-4580(20)30075.
    PubMed    


  202. CERVERA-CARLES L, Dols-Icardo O, Molina-Porcel L, Alcolea D, et al
    Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration.
    Neurobiol Aging. 2020;92:7-11.
    PubMed     Abstract available


  203. CHIESA PA, Houot M, Vergallo A, Cavedo E, et al
    Association of brain network dynamics with plasma biomarkers in subjective memory complainers.
    Neurobiol Aging. 2020;88:83-90.
    PubMed     Abstract available


    March 2020
  204. LIM B, Sando SB, Grontvedt GR, Brathen G, et al
    Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study.
    Neurobiol Aging. 2020 Mar 31. pii: S0197-4580(20)30098.
    PubMed     Abstract available


  205. REUS LM, Stringer S, Posthuma D, Teunissen CE, et al
    Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid.
    Neurobiol Aging. 2020 Mar 24. pii: S0197-4580(20)30091.
    PubMed     Abstract available


  206. WALSH P, Sudre CH, Fiford CM, Ryan NS, et al
    CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
    Neurobiol Aging. 2020;91:5-14.
    PubMed     Abstract available


  207. TEIPEL SJ, Dyrba M, Chiesa PA, Sakr F, et al
    In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease.
    Neurobiol Aging. 2020 Mar 17. pii: S0197-4580(20)30090.
    PubMed     Abstract available


  208. KOCAGONCU E, Quinn A, Firouzian A, Cooper E, et al
    Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics.
    Neurobiol Aging. 2020 Mar 17. pii: S0197-4580(20)30086.
    PubMed     Abstract available


  209. ZHANG W, Zhang Q, Yang Q, Liu P, et al
    Contribution of Alzheimer's disease neuropathologic change to the cognitive dysfunction in human brains with Lewy body-related pathology.
    Neurobiol Aging. 2020 Mar 4. pii: S0197-4580(20)30055.
    PubMed     Abstract available


  210. WANG Y, Yang Y, Zhang S, Li C, et al
    Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.
    Neurobiol Aging. 2020;87:1-10.
    PubMed     Abstract available


  211. LONG JM, Perez EJ, Roberts JA, Roberts MT, et al
    Reelin in the Years: decline in the number of reelin immunoreactive neurons in layer II of the entorhinal cortex in aged monkeys with memory impairment.
    Neurobiol Aging. 2020;87:132-137.
    PubMed     Abstract available


    February 2020
  212. WANG Z, Meng L, Shen L, Ji HF, et al
    Impact of modifiable risk factors on Alzheimer's disease: A two-sample Mendelian randomization study.
    Neurobiol Aging. 2020 Feb 27. pii: S0197-4580(20)30051.
    PubMed     Abstract available


  213. COUGHLAN G, Zhukovsky P, Puthusseryppady V, Gillings R, et al
    Functional connectivity between the entorhinal and posterior cingulate cortices underpins navigation discrepancies in at-risk Alzheimer's disease.
    Neurobiol Aging. 2020 Feb 19. pii: S0197-4580(20)30034.
    PubMed     Abstract available


  214. GUILLEMAUD O, Ceyzeriat K, Saint-Georges T, Cambon K, et al
    Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease.
    Neurobiol Aging. 2020 Feb 18. pii: S0197-4580(20)30037.
    PubMed     Abstract available


  215. KRISHNAN D, Menon RN, Mathuranath PS, Gopala S, et al
    A novel role for SHARPIN in amyloid-beta phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease.
    Neurobiol Aging. 2020 Feb 13. pii: S0197-4580(20)30028.
    PubMed     Abstract available


  216. CACERES A, Jene A, Esko T, Perez-Jurado LA, et al
    Extreme downregulation of chromosome Y and Alzheimer's disease in men.
    Neurobiol Aging. 2020 Feb 13. pii: S0197-4580(20)30030.
    PubMed     Abstract available


  217. VANCE E, Gonzalez Murcia JD, Miller JB, Staley L, et al
    Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.
    Neurobiol Aging. 2020 Feb 12. pii: S0197-4580(20)30027.
    PubMed     Abstract available


  218. JAKIMOVSKI D, Bergsland N, Dwyer MG, Hagemeier J, et al
    Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
    Neurobiol Aging. 2020 Feb 8. pii: S0197-4580(20)30029.
    PubMed     Abstract available


  219. NADAL L, Coupe P, Helmer C, Manjon JV, et al
    Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer's clinical syndrome.
    Neurobiol Aging. 2020 Feb 1. pii: S0197-4580(20)30025.
    PubMed     Abstract available


  220. BABILONI C, Lopez S, Del Percio C, Noce G, et al
    Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD study.
    Neurobiol Aging. 2020 Feb 1. pii: S0197-4580(20)30026.
    PubMed     Abstract available


  221. KELLER LJ, Sekula NM, Svirsky S, Maesako M, et al
    Presenilin 1 increases association with synaptotagmin 1 during normal aging.
    Neurobiol Aging. 2020;86:156-161.
    PubMed     Abstract available


  222. KIM CM, Alvarado RL, Stephens K, Wey HY, et al
    Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.
    Neurobiol Aging. 2020;86:64-74.
    PubMed     Abstract available


  223. DUPONT PS, Bocti C, Joannette M, Lavallee MM, et al
    Amyloid burden and white matter hyperintensities mediate age-related cognitive differences.
    Neurobiol Aging. 2020;86:16-26.
    PubMed     Abstract available


    January 2020
  224. TADAYON E, Pascual-Leone A, Press D, Santarnecchi E, et al
    Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease.
    Neurobiol Aging. 2020 Jan 16. pii: S0197-4580(20)30013.
    PubMed     Abstract available


  225. OLIVITO G, Serra L, Marra C, Di Domenico C, et al
    Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer's disease and memory: a seed-based approach.
    Neurobiol Aging. 2020 Jan 15. pii: S0197-4580(20)30011.
    PubMed     Abstract available


  226. PISHVA E, Creese B, Smith AR, Viechtbauer W, et al
    Psychosis-associated DNA methylomic variation in Alzheimer's disease cortex.
    Neurobiol Aging. 2020 Jan 8. pii: S0197-4580(20)30001.
    PubMed     Abstract available


  227. MCKENZIE C, Bucks RS, Weinborn M, Bourgeat P, et al
    Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology.
    Neurobiol Aging. 2020 Jan 3. pii: S0197-4580(19)30451.
    PubMed     Abstract available


  228. ZOU J, Tao S, Johnson A, Tomljanovic Z, et al
    Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment.
    Neurobiol Aging. 2020;85:11-21.
    PubMed     Abstract available


    December 2019
  229. LEE YH, Bak Y, Park CH, Chung SJ, et al
    Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia.
    Neurobiol Aging. 2019 Dec 30. pii: S0197-4580(19)30450.
    PubMed     Abstract available


  230. BATZU L, Westman E, Pereira JB
    Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.
    Neurobiol Aging. 2019 Dec 20. pii: S0197-4580(19)30440.
    PubMed     Abstract available


  231. PETTIGREW C, Soldan A, Zhu Y, Cai Q, et al
    Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.
    Neurobiol Aging. 2019 Dec 17. pii: S0197-4580(19)30431.
    PubMed     Abstract available


  232. COSTUMERO V, Uquillas FD, Diez I, Andorra M, et al
    Distance disintegration delineates the brain connectivity failure of Alzheimer's disease.
    Neurobiol Aging. 2019 Dec 14. pii: S0197-4580(19)30433.
    PubMed     Abstract available


  233. WALSH DA, Brown JT, Randall AD
    Neurophysiological alterations in the nucleus reuniens of a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2019;88:1-10.
    PubMed     Abstract available


  234. LI A, Zhao J, Fan C, Zhu L, et al
    Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease.
    Neurobiol Aging. 2019 Dec 11. pii: S0197-4580(19)30375.
    PubMed     Abstract available


  235. PARK YH, Hodges A, Risacher SL, Lin K, et al
    Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis.
    Neurobiol Aging. 2019 Dec 10. pii: S0197-4580(19)30428.
    PubMed     Abstract available


    November 2019
  236. YEH SH, Shie FS, Liu HK, Yao HH, et al
    A high-sucrose diet aggravates Alzheimer's disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice.
    Neurobiol Aging. 2019 Nov 27. pii: S0197-4580(19)30426.
    PubMed     Abstract available


  237. LU X, Moeini M, Li B, de Montgolfier O, et al
    Voluntary exercise increases brain tissue oxygenation and spatially homogenizes oxygen delivery in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 27. pii: S0197-4580(19)30423.
    PubMed     Abstract available


  238. NICOLAS B, Alessandra D, Daniela P, Osman R, et al
    Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education.
    Neurobiol Aging. 2019 Nov 27. pii: S0197-4580(19)30419.
    PubMed     Abstract available


  239. BHARANI KL, Ledreux A, Gilmore A, Carroll SL, et al
    Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 22. pii: S0197-4580(19)30409.
    PubMed     Abstract available


  240. LYROS E, Ragoschke-Schumm A, Kostopoulos P, Sehr A, et al
    Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine (1)H-MR spectroscopy study.
    Neurobiol Aging. 2019 Nov 22. pii: S0197-4580(19)30411.
    PubMed     Abstract available


  241. PERROTTE M, Haddad M, Le Page A, Frost EH, et al
    Profile of pathogenic proteins in total circulating extracellular vesicles in mild cognitive impairment and during the progression of Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 15. pii: S0197-4580(19)30373.
    PubMed     Abstract available


  242. LY M, Yu GZ, Karim HT, Muppidi NR, et al
    Improving brain age prediction models: incorporation of amyloid status in Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 14. pii: S0197-4580(19)30394.
    PubMed     Abstract available


  243. BONFILI L, Cecarini V, Gogoi O, Berardi S, et al
    Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 11. pii: S0197-4580(19)30393.
    PubMed     Abstract available


  244. KULMINSKI AM, Shu L, Loika Y, Nazarian A, et al
    APOE region molecular signatures of Alzheimer's disease across races/ethnicities.
    Neurobiol Aging. 2019 Nov 11. pii: S0197-4580(19)30396.
    PubMed     Abstract available


  245. NASROUEI S, Rattel JA, Liedlgruber M, Marksteiner J, et al
    Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 11. pii: S0197-4580(19)30392.
    PubMed     Abstract available


  246. SHEPHERD CE, Affleck AJ, Bahar AY, Carew-Jones F, et al
    Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Abeta and tau pathology.
    Neurobiol Aging. 2019 Nov 8. pii: S0197-4580(19)30389.
    PubMed     Abstract available


  247. YE BS, Lee S, Yoo H, Chung SJ, et al
    Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Neurobiol Aging. 2019 Nov 5. pii: S0197-4580(19)30384.
    PubMed     Abstract available


  248. MOORE AM, Mahoney E, Dumitrescu L, De Jager PL, et al
    APOE epsilon4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 5. pii: S0197-4580(19)30385.
    PubMed     Abstract available


  249. HUO Z, Yu L, Yang J, Zhu Y, et al
    Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Neurobiol Aging. 2019 Nov 5. pii: S0197-4580(19)30377.
    PubMed     Abstract available


  250. CONTRERAS JA, Aslanyan V, Sweeney MD, Sanders LMJ, et al
    Functional connectivity among brain regions affected in Alzheimer's disease is associated with CSF TNF-alpha in APOE4 carriers.
    Neurobiol Aging. 2019 Nov 5. pii: S0197-4580(19)30376.
    PubMed     Abstract available


  251. ROSAS I, Martinez C, Clarimon J, Lleo A, et al
    Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
    Neurobiol Aging. 2019 Nov 1. pii: S0197-4580(19)30381.
    PubMed     Abstract available


    October 2019
  252. JANG H, Jang YK, Park S, Kim SE, et al
    Presynaptic dopaminergic function in early-onset Alzheimer's disease: an FP-CIT image study.
    Neurobiol Aging. 2019 Oct 21. pii: S0197-4580(19)30370.
    PubMed     Abstract available


  253. JOHANSSON M, Stomrud E, Lindberg O, Westman E, et al
    Apathy and anxiety are early markers of Alzheimer's disease.
    Neurobiol Aging. 2019 Oct 19. pii: S0197-4580(19)30371.
    PubMed     Abstract available


  254. RIPHAGEN JM, Ramakers IHGM, Freeze WM, Pagen LHG, et al
    Linking APOE-epsilon4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.
    Neurobiol Aging. 2019 Oct 15. pii: S0197-4580(19)30355.
    PubMed     Abstract available


  255. BENWELL CSY, Davila-Perez P, Fried PJ, Jones RN, et al
    EEG spectral power abnormalities and their relationship with cognitive dysfunction in patients with Alzheimer's disease and type 2 diabetes.
    Neurobiol Aging. 2019 Oct 14. pii: S0197-4580(19)30359.
    PubMed     Abstract available


    September 2019
  256. NETH BJ, Mintz A, Whitlow C, Jung Y, et al
    Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
    Neurobiol Aging. 2019 Sep 26. pii: S0197-4580(19)30336.
    PubMed     Abstract available


  257. ANDREWS SJ, Fulton-Howard B, Patterson C, McFall GP, et al
    Mitonuclear interactions influence Alzheimer's disease risk.
    Neurobiol Aging. 2019 Sep 24. pii: S0197-4580(19)30328.
    PubMed     Abstract available


  258. KARANFILIAN L, Tosto MG, Malki K
    The role of triggering receptor expressed on myeloid cells 2 in Alzheimer's disease: evidence from transgenic mouse models.
    Neurobiol Aging. 2019 Sep 23. pii: S0197-4580(19)30325.
    PubMed     Abstract available


  259. VOGLEIN J, Willem M, Trambauer J, Schonecker S, et al
    Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-beta processing effects.
    Neurobiol Aging. 2019 Sep 20. pii: S0197-4580(19)30320.
    PubMed     Abstract available


  260. BABILONI C, Blinowska K, Bonanni L, Cichocki A, et al
    What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons.
    Neurobiol Aging. 2019;85:58-73.
    PubMed     Abstract available


  261. TABATABAEI-JAFARI H, Shaw ME, Walsh E, Cherbuin N, et al
    Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume.
    Neurobiol Aging. 2019;83:86-94.
    PubMed     Abstract available


  262. TOSCHI N, Lista S, Baldacci F, Cavedo E, et al
    Biomarker-guided clustering of Alzheimer's disease clinical syndromes.
    Neurobiol Aging. 2019;83:42-53.
    PubMed     Abstract available


  263. ANDREWS SJ, Goate A
    Mendelian randomization indicates that TNF is not causally associated with Alzheimer's disease.
    Neurobiol Aging. 2019 Sep 9. pii: S0197-4580(19)30323.
    PubMed     Abstract available


  264. KREMEN WS, Panizzon MS, Elman JA, Granholm EL, et al
    Pupillary dilation responses as a midlife indicator of risk for Alzheimer's disease: association with Alzheimer's disease polygenic risk.
    Neurobiol Aging. 2019;83:114-121.
    PubMed     Abstract available


    August 2019
  265. BAGYINSZKY E, Kang MJ, Van Giau V, Shim K, et al
    Novel amyloid precursor protein mutation, Val669Leu ("Seoul APP"), in a Korean patient with early-onset Alzheimer's disease.
    Neurobiol Aging. 2019 Aug 31. pii: S0197-4580(19)30305.
    PubMed     Abstract available


  266. LI P, Yu L, Yang J, Lo MT, et al
    Interaction between the progression of Alzheimer's disease and fractal degradation.
    Neurobiol Aging. 2019;83:21-30.
    PubMed     Abstract available


  267. CHOU YH, Ton That V, Sundman M
    A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging. 2019;86:1-10.
    PubMed     Abstract available


  268. WOHLERS I, Schulz C, Kilpert F, Bertram L, et al
    Alzheimer's disease risk SNPs show no strong effect on miRNA expression in human lymphoblastoid cell lines.
    Neurobiol Aging. 2019 Aug 20. pii: S0197-4580(19)30291.
    PubMed     Abstract available


    July 2019
  269. SLOT RER, Kester MI, Van Harten AC, Jongbloed W, et al
    ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Abeta42, levels in non-demented elderly.
    Neurobiol Aging. 2019;79:101-109.
    PubMed     Abstract available


  270. FRANZ CE, Xian H, Lew D, Hatton SN, et al
    Body mass trajectories and cortical thickness in middle-aged men: a 42-year longitudinal study starting in young adulthood.
    Neurobiol Aging. 2019;79:11-21.
    PubMed     Abstract available


    May 2019
  271. TOMADESSO C, Gonneaud J, Egret S, Perrotin A, et al
    Is there a specific memory signature associated with Abeta-PET positivity in patients with amnestic mild cognitive impairment?
    Neurobiol Aging. 2019;77:94-103.
    PubMed     Abstract available


  272. MAKKINEJAD N, Schneider JA, Yu J, Leurgans SE, et al
    Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults.
    Neurobiol Aging. 2019;77:104-111.
    PubMed     Abstract available


    April 2019
  273. HUA J, Lee S, Blair NIS, Wyss M, et al
    Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-beta-related cognitive decline.
    Neurobiol Aging. 2019;76:181-193.
    PubMed     Abstract available


  274. WU M, Thurston RC, Tudorascu DL, Karim HT, et al
    Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus women.
    Neurobiol Aging. 2019;76:141-150.
    PubMed     Abstract available


  275. DADAR M, Maranzano J, Ducharme S, Collins DL, et al
    White matter in different regions evolves differently during progression to dementia.
    Neurobiol Aging. 2019;76:71-79.
    PubMed     Abstract available


    February 2019
  276. AVANTS BB, Hutchison RM, Mikulskis A, Salinas-Valenzuela C, et al
    Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity.
    Neurobiol Aging. 2019;74:191-201.
    PubMed     Abstract available


  277. HANKO V, Apple AC, Alpert KI, Warren KN, et al
    In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.
    Neurobiol Aging. 2019;74:171-181.
    PubMed     Abstract available


  278. KIM HJ, Park JY, Seo SW, Jung YH, et al
    Cortical atrophy pattern-based subtyping predicts prognosis of amnestic MCI: an individual-level analysis.
    Neurobiol Aging. 2019;74:38-45.
    PubMed     Abstract available


  279. DELLI PIZZI S, Punzi M, Sensi SL
    Functional signature of conversion of patients with mild cognitive impairment.
    Neurobiol Aging. 2019;74:21-37.
    PubMed     Abstract available


    January 2019
  280. SULLIVAN MD, Anderson JAE, Turner GR, Spreng RN, et al
    Intrinsic neurocognitive network connectivity differences between normal aging and mild cognitive impairment are associated with cognitive status and age.
    Neurobiol Aging. 2019;73:219-228.
    PubMed     Abstract available


  281. SOLTYS DT, Pereira CPM, Rowies FT, Farfel JM, et al
    Lower mitochondrial DNA content but not increased mutagenesis associates with decreased base excision repair activity in brains of AD subjects.
    Neurobiol Aging. 2019;73:161-170.
    PubMed     Abstract available


  282. MOSER VA, Christensen A, Liu J, Zhou A, et al
    Effects of aging, high-fat diet, and testosterone treatment on neural and metabolic outcomes in male brown Norway rats.
    Neurobiol Aging. 2019;73:145-160.
    PubMed     Abstract available


  283. LACHEN-MONTES M, Gonzalez-Morales A, Iloro I, Elortza F, et al
    Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
    Neurobiol Aging. 2019;73:123-134.
    PubMed     Abstract available


  284. ZOKAEI N, Cepukaityte G, Board AG, Mackay CE, et al
    Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories.
    Neurobiol Aging. 2019;73:115-122.
    PubMed     Abstract available


  285. HODGETTS CJ, Shine JP, Williams H, Postans M, et al
    Increased posterior default mode network activity and structural connectivity in young adult APOE-epsilon4 carriers: a multimodal imaging investigation.
    Neurobiol Aging. 2019;73:82-91.
    PubMed     Abstract available


  286. MAK E, Donaghy PC, McKiernan E, Firbank MJ, et al
    Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
    Neurobiol Aging. 2019;73:74-81.
    PubMed     Abstract available


  287. HAN SH, Park JC, Byun MS, Yi D, et al
    Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals.
    Neurobiol Aging. 2019;73:21-29.
    PubMed     Abstract available


  288. RANTALAINEN V, Lahti J, Kajantie E, Tienari P, et al
    APOE varepsilon4, rs405509, and rs440446 promoter and intron-1 polymorphisms and dementia risk in a cohort of elderly Finns-Helsinki Birth Cohort Study.
    Neurobiol Aging. 2019;73:230.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: